Preclinical study in mice. RDC018 effectively inhibited the recruitment of tumour-infiltrating monocytes and the “M2-like” polarisation of TAMs in an orthotopic liver tumour model. This resulted in reversal of the immunosuppression status of the TME and activation of an anti-tumour CD8+ T-cell response. The gene discussed is CD8A; the disease is neoplasm.